Form 4: Astrana Health CEO Brandon Sim Reports Stock Transactions
SEC Form 4 Filing
Astrana Health's CEO, Brandon Sim, reported the acquisition and disposal of company stock, including restricted stock units and shares surrendered for tax obligations.
Summary
- On March 5, 2025, Brandon Sim, CEO and President of Astrana Health, Inc., reported transactions involving the company's common stock.
- Sim acquired 145,642 shares of common stock through a grant of restricted stock units.
- He also disposed of 105,795 shares to cover tax withholding obligations related to the vesting of restricted stock at a price of $27.19 per share.
- Following these transactions, Sim directly owns 1,023,219 shares and indirectly owns 651,640 shares through family trusts.
- The restricted stock units vest in semi-annual installments, contingent upon continued employment.
Sentiment
Score: 5
Explanation: The document is a neutral report of stock transactions, with no inherent positive or negative sentiment.
Positives
- The grant of restricted stock units aligns the CEO's interests with the company's long-term performance.
- Sim's continued employment is required for the vesting of the restricted stock units, incentivizing his commitment to the company.
Negatives
- The disposal of shares to cover tax obligations reduces Sim's direct holdings in the company.
Risks
- The vesting of restricted stock units is contingent upon continued employment, creating a potential risk if Sim were to leave the company.
- Fluctuations in the stock price could impact the value of Sim's holdings and the attractiveness of the restricted stock units.
Future Outlook
The document outlines the vesting schedule for restricted stock units, indicating future increases in Sim's holdings contingent upon continued employment.
Industry Context
Form 4 filings are standard practice for company insiders to report transactions in their company's stock, providing transparency to investors.
Comparison to Industry Standards
- Insider transactions are common across publicly traded companies, and the reporting requirements are standardized by the SEC.
- The vesting schedules for restricted stock units are typical for executive compensation packages, aligning management's interests with shareholder value.
Stakeholder Impact
- Shareholders may be interested in the CEO's stock transactions as an indicator of his confidence in the company's future.
- The vesting of restricted stock units could potentially dilute existing shareholders' ownership.
Next Steps
- Continued monitoring of insider transactions to assess management's confidence in the company.
- Tracking the vesting of restricted stock units to understand the potential dilution of existing shareholders.
Key Dates
| Date | Description |
|---|---|
| 03/05/2025 | Date of stock acquisition and disposal. |
| 03/07/2025 | Date of signature on the Form 4. |
| 03/31/2025 | Start date for vesting of 85,513 restricted shares in semi-annual installments. |
| 04/02/2025 | Start date for vesting of 105,605 restricted stock units in semi-annual installments. |
| 06/27/2025 | Date for first annual installment vesting of 59,837 restricted shares. |
| 09/05/2025 | Start date for vesting of 145,642 restricted stock units in semi-annual installments. |
| 06/27/2026 | Date for second annual installment vesting of 59,837 restricted shares. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.